Although PD-L1/PD-1 as targets for immunotherapy have been identified and the prognosis of most immunotherapy cancer patients has been effectively improved, such as lung cancer (10), breast cancer (11) and haematological tumours (12), immunotherapy for OC is not very effective (13). The gene discussed is CD274; the disease is breast carcinoma.